PLK4 as a Novel Therapeutic Target in TP53-mutant Acute Myeloid Leukemia

Authors

• Sima Fay Koyfman, Bryn Mawr CollegeFollow
• Jingqi Pei PhD, The University of Texas MD Anderson Cancer Center
• Po Yee Mak MS, The University of Texas MD Anderson Cancer CenterFollow
• Edward Ayoub PhD, The University of Texas MD Anderson Cancer Center
• Michael Andreeff MD, PhD, The University of Texas MD Anderson Cancer Center
• Bing Z. Carter PhD, The University of Texas MD Anderson Cancer CenterFollow

Files

Program Affiliation

University Outreach - Bryn Mawr College

Recommended Citation

Koyfman, Sima Fay; Pei, Jingqi PhD; Mak, Po Yee MS; Ayoub, Edward PhD; Andreeff, Michael MD, PhD; and Carter, Bing Z. PhD, "PLK4 as a Novel Therapeutic Target in TP53-mutant Acute Myeloid Leukemia" (2023). Summer Experience 2023. 54.
https://openworks.mdanderson.org/sumexp23/54

Keywords

AML; TP53; PLK4; Polyploidy; Apoptosis